Hepatitis B and hepatitis C

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 993 indexed papers.

1 Asselah T, Chattergoon MA, Jucov A, Streinu-Cercel A, Lampertico P, Wedemeyer H et al.. A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. The New England journal of medicine 2026. link 2 Verma M, Tahir H, Kalman R. Implementation science: a primer for hepatology research. Current opinion in gastroenterology 2026. link 3 Uttal S, Aby ES, Rabiee A, Winters A, Sharma P, Davis JPE. Building bridges: The power of near-peer mentorship in hepatology. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2026. link 4 Chan HLY, Lee JML, Cheng CFY, Chan AFS, Tung DMC, Wong GLH et al.. Evaluation of Factors Influencing Specialist Referral Among Individuals Tested Positive for HBsAg in Health Check Programs in Hong Kong. Journal of gastroenterology and hepatology 2026. link 5 Kushner T, Buti M, El-Kassas M, Yilmaz Y, Takahashi H, Eguchi Y et al.. Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey. Liver international : official journal of the International Association for the Study of the Liver 2026. link 6 Liu Z, Geng T, Ji Y, Zeng M, Wang M. Focal peliosis hepatis: magnetic resonance imaging manifestations and diffusion characteristics. Abdominal radiology (New York) 2026. link 7 Hvitmyhr C, Enga KF, Øverbø J, Midgard H, Reikvam DH. A man in his 60s with immunodeficiency and hepatitis. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2026. link 8 Fall NM, Mena AR, Wembulua BS, Tine J, Ka D, Gaye A et al.. Metabolic multimorbidity and liver fibrosis among people with hepatitis B in Senegal. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 9 Bansal S, Mahajan A, Mantan M. Rare but real: Unusual manifestations of hepatitis A. Tropical doctor 2026. link 10 Ali FS, Nguyen MH, Hernaez R, Huang DQ, Wilder J, Piscoya A et al.. AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals. Gastroenterology 2025. link 11 Clusmann J, Balaguer-Montero M, Bassegoda O, Schneider CV, Seraphin T, Paintsil E et al.. The barriers to uptake of artificial intelligence in hepatology and how to overcome them. Journal of hepatology 2025. link 12 . EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of hepatology 2025. link 13 Pan CQ, Dai E, Mo Z, Zhang H, Zheng TQ, Wang Y et al.. Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial. JAMA 2025. link 14 Chen J, Ji D, Jia J, Zhuang H, Zhang X, Wang FS et al.. Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis. Hepatology international 2025. link 15 Hardtke S, Yurdaydin C, Caruntu FA, Curescu MG, Yalcin K, Akarca US et al.. Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection. Journal of viral hepatitis 2025. link 16 Liu X, Zang X, Zhu K, Huang X, Hu X, Bi Z et al.. Long-term protection from naturally acquired immunity against hepatitis E virus reinfection. Nature communications 2025. link 17 Chang L, Li Z, Liu Y, Fei S, Zhao L, Li J et al.. Immunogenicity and safety of hepatitis A vaccine at different vaccination intervals among adults aged 18 years and above: Interim results. Human vaccines & immunotherapeutics 2025. link 18 Nóbile AL, Adri AS, Usuda JN, Vale FYND, Corrêa YLG, Freitas DGA et al.. The Neuroimmunome of Hepatitis Patients Associates With Disease Severity. Journal of medical virology 2025. link 19 Andani A, Mellou K, Dewda P, Eeuwijk J, Kassianos G, Van Damme P et al.. Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years. Journal of viral hepatitis 2025. link 20 Temesgen MM, Legesse M, Haile AF, Shiferaw B, Dessie T, Berhe N. Risk factors associated with hepatitis B virus infection among patients attending gastroenterology outpatient department at public hospitals in Northeast Ethiopia: a hospital-based unmatched case-control study. BMC infectious diseases 2025. link 21 Remy AJ, Bellon S, Smadhi R, Bottlaender J, Rosa I, Vidon M et al.. HCV Screening Before Endoscopy in Hepatogastroenterology Outpatient Clinic: The Depist C Endo Study. Journal of viral hepatitis 2025. link 22 Talavlikar R, Hull AR, Marlinga J, Soquar B, Congly SE, Lee SS. A shared care program for the management of patients with chronic hepatitis B in a Canadian primary care refugee clinic. Public health 2025. link 23 Trickey A, Artenie A, Feld JJ, Vickerman P. Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis study. The lancet. Gastroenterology & hepatology 2025. link00189-X) 24 Zubair S, Parvaiz F, Abualait T, Al-Regaiey K, Anwar T, Zafar M et al.. Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques. PloS one 2025. link 25 Ren L, Wang J, Jiang R, Han Y, Li X, Zhang W et al.. Safety Surveillance for Hepatitis A Vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database. Human vaccines & immunotherapeutics 2025. link 26 Yu L, Xiang Q, Liu L. Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system. PloS one 2025. link 27 Zhou H, Yang J, Zhang J, Liu P, Yao D. A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database. Scientific reports 2025. link 28 Zhang C, Wen J, Li Y. A real-world disproportionality analysis of Tenofovir Alafenamide (TAF): Data mining of the FDA adverse event reporting system (FAERS). PloS one 2025. link 29 Sun Y, Zhu B, Li X, Luo Z, Bian W. Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system. Frontiers in public health 2025. link 30 Zhou Y, Wang Y, Feng Y, Zhang H, Sun T, Xu J. Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system. Frontiers in cellular and infection microbiology 2025. link 31 Reiberger T, Lens S, Cabibbo G, Nahon P, Zignego AL, Deterding K et al.. EASL position paper on clinical follow-up after HCV cure. Journal of hepatology 2024. link 32 Mei T, Huang X, Tang S, Liu M, Zhang W, Yu H. Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis. Lipids in health and disease 2024. link 33 Allweiss L, Volmari A, Suri V, Wallin JJ, Flaherty JF, Manuilov D et al.. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. Journal of hepatology 2024. link 34 Asselah T, Chulanov V, Lampertico P, Wedemeyer H, Streinu-Cercel A, Pântea V et al.. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D. The New England journal of medicine 2024. link 35 Adeiza S, Islam M, Mungadi H, Shuaibu A, Sah R. A preregistered meta-meta-analysis on the global distribution of Hepatotropic Viruses. Voprosy virusologii 2024. link 36 Simpore A, Bazie BVEJT, Yooda PA, Zoure AA, Sawadogo S, Sawadogo AG et al.. Seroprevalence of Viral Hepatitis B and Occult Hepatitis B Among Blood Donors in Africa: A Systematic Review and Meta-Analysis. Reviews in medical virology 2024. link 37 Mouzannar K, Schauer A, Liang TJ. The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy. Viruses 2024. link 38 Wong RJ, Hirode G, Feld J, Wong SS, Brosgart C, Glenn J et al.. An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis. Journal of viral hepatitis 2024. link 39 Zhao P, Zhao Y, Du M, Chen X, Lu Y. Impact of lamivudine treatment in late pregnancy on the development of the foetal immune response to hepatitis B virus: a meta-analysis in R with the metafor package. Transactions of the Royal Society of Tropical Medicine and Hygiene 2024. link 40 Li G, Yang D, Liu X, Zhang T, Liu H, Zou J et al.. Precore mutation enhances viral replication to facilitate persistent infection especially in HBeAg-negative patients. Virologica Sinica 2024. link 41 Virtudazo MCC, Aquino JB, Arellano RNB, Fortes RA, Kaw RC, Tantengco OAG. The role of dried blood spot tests in the detection of hepatitis B infection: A systematic review. Journal of viral hepatitis 2024. link 42 Solomon-Rakiep T, Olivier J, Amponsah-Dacosta E. Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: a qualitative systematic review. Frontiers in public health 2024. link 43 Cespiati A, Coelho Rodrigues I, Santos I, Policarpo S, Carvalhana S, Fracanzani AL et al.. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review. Liver international : official journal of the International Association for the Study of the Liver 2024. link 44 . Gamal Shiha: eliminating hepatitis C. Bulletin of the World Health Organization 2024. link 45 Santos CCD, Leite BO, Lima FWM, Magno L, Grangeiro A, Westin M et al.. Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil. Revista de saude publica 2024. link 46 Rao S, Qazi S, Lee D, Molliner C, Martin P, Jones PD. Multiple Barriers Impede Screening for Hepatitis Delta: An Internet-Based Survey of Healthcare Providers. The American journal of gastroenterology 2024. link 47 Kumari K, Pahuja SK, Kumar S. A Comprehensive Examination of ChatGPT's Contribution to the Healthcare Sector and Hepatology. Digestive diseases and sciences 2024. link 48 Ogasawara N. A GLOBAL VIEW OF HEPATOLOGY COLLABORATION: INSIGHTS AND FUTURE DIRECTIONS FROM 30 YEARS OF NETWORK ANALYSIS (1994-2023). Arquivos de gastroenterologia 2024. link 49 Moore JD, Nguyen UDT, Ojha RP, Griner SB, Thompson EL. Physician-level determinants of HCV screening during pregnancy in a U.S. sample. Archives of gynecology and obstetrics 2024. link 50 Berry AJ. The Power of a Simple Question. Anesthesiology 2024. link 51 Naully PG, Tan MI, Nugrahapraja H, Artarini AA, Aditama R, Giri-Rachman EA. Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches. PloS one 2024. link 52 Ahmad S, Demneh FM, Rehman B, Almanaa TN, Akhtar N, Pazoki-Toroudi H et al.. In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approaches. International journal of biological macromolecules 2024. link 53 Ridge LJ, Arko-Mensah J, Lambert J, Aziato L, Zeantoe GC, Duah H et al.. Sharps injuries among healthcare workers in Liberia and Ghana: a cross-sectional survey. International journal for quality in health care : journal of the International Society for Quality in Health Care 2024. link 54 Wang J, Jiang H, Zhang G, Dai X, Gao H, Li L. Real-World Pharmacovigilance Study Identifies Drugs Linked to Hepatitis B Virus Reactivation. Journal of medical virology 2024. link 55 Mokhles MA. Extrahepatic manifestations of HCV where do we stand?. Medicina clinica 2024. link 56 Hernandez-Con P, Wilson DL, Tang H, Unigwe I, Riaz M, Ourhaan N et al.. Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis. American journal of preventive medicine 2023. link 57 Magri MC, Manchiero C, Dantas BP, da Silva Nunes AK, Vaz Gago Prata T, Domingos DEA et al.. Hepatitis C Among People Who Inject Drugs (PWID) in Latin America and the Caribbean: A Meta-Analysis of Prevalence Over Three Decades. Journal of studies on alcohol and drugs 2023. link 58 Perazzo H, Castro R, Villela-Nogueira C, Torres M, Silva SL, Cardoso SW et al.. Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis. Journal of viral hepatitis 2023. link 59 Huang J, Liu Y, Liu Y. Antiviral therapy in hepatitis B virus-infected with immune-tolerant: A meta-analysis. Gastroenterologia y hepatologia 2023. link 60 Uraz S, Deniz Z, Zerdali EY, Araslanova A, Tahan V, Tabak F et al.. The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review. Journal of viral hepatitis 2023. link 61 Li H, Niu X, Zhang Y, Zhang D, Zhang Y, Wang L et al.. Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ-73763989 in Healthy Chinese Adult Participants. Clinical pharmacology in drug development 2023. link 62 Hussain T. Self-flagellation: An Unaddressed Risk Factor of Hepatitis B and C Transmission among Shiite Muslims. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2023. link 63 Cui F, Blach S, Manzengo Mingiedi C, Gonzalez MA, Sabry Alaama A, Mozalevskis A et al.. Global reporting of progress towards elimination of hepatitis B and hepatitis C. The lancet. Gastroenterology & hepatology 2023. link00386-7) 64 Tolera S, Mengistu DA, Alemu FK, Geremew A, Mulugeta Y, Dirirsa G et al.. Sero-prevalence of hepatitis viral infections among sanitary workers across worldwide: a systematic review and meta-analysis. BMC infectious diseases 2023. link 65 Takuissu GR, Kenmoe S, Ebogo-Belobo JT, Kengne-Ndé C, Mbaga DS, Bowo-Ngandji A et al.. Occurrence of Hepatitis A Virus in Water Matrices: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 2023. link 66 Caminada S, Mele A, Ferrigno L, Alfonsi V, Crateri S, Iantosca G et al.. Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021. Journal of hepatology 2023. link 67 Leslie M. White House budget includes push to eliminate hepatitis C. Science (New York, N.Y.) 2023. link 68 Lole KS, Thorat NC, Bhukya PL, Ramdasi AY, Hundekar SL, Patil AR et al.. Circulation of a single hepatitis A virus genotype IIIA with two distinct clusters in different states of India. Indian journal of medical microbiology 2023. link 69 Lasagna A, Pedrazzoli P, Bruno R, Sacchi P. Postvaccination immune-mediated hepatitis: what do we really know?. Immunotherapy 2023. link 70 Sallustro M, Marrone A, Florio A. A Case Report on Treatment of Nonhealing Leg Ulcer: Do Not Forget the Underlying Disease. The international journal of lower extremity wounds 2023. link 71 Wang R, Zhu X, Zhang X, Liu H, Ji YL, Chen YH. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B. World journal of gastroenterology 2023. link 72 Wu L, Yang S, Huang Z, Liu J, Guo X, Bai Q et al.. Safety of concomitant administration of inactivated hepatitis A vaccine with other vaccines in children under 16 years old in post-marketing surveillance. Vaccine 2023. link 73 Rodríguez-Espinosa D, Rodas L, Cuadrado E, Hermida E, Piñeiro GJ, Molina A et al.. Acute hepatitis post arteriovenous graft thrombectomy of hemodialysis vascular access. The journal of vascular access 2023. link 74 Lam L, Fontaine H, Lapidus N, Dorival C, Bellet J, Larrey D et al.. Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers. Pharmacoepidemiology and drug safety 2023. link 75 Wu VC, Huang CH, Wang CL, Lin MH, Kuo TY, Chang CH et al.. Cardiovascular outcomes in hepatitis C virus infected patients treated with direct acting antiviral therapy: a retrospective multi-institutional study. European heart journal. Cardiovascular pharmacotherapy 2023. link 76 Cichos KH, Jordan E, Niknam K, Chen AF, Hansen EN, McGwin G et al.. Child-Pugh Class B or C Liver Disease Increases the Risk of Early Mortality in Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty Regardless of Treatment Status. Clinical orthopaedics and related research 2023. link 77 Souza-Silva G, Zolnikov TR, Ortolani PL, Cruvinel VRN, Dias SM, Mol MPG. Hepatitis B and C prevalence in waste pickers: a global meta-analysis. Journal of public health (Oxford, England) 2022. link 78 Tran A, Shili-Masmoudi S, Moga L, Chevaliez S, Luciani A, Ruiz I et al.. Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus. Clinics and research in hepatology and gastroenterology 2022. link 79 Leroy V, Chevaliez S, Decraecker M, Roulot D, Nana J, Asselah T et al.. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus. Clinics and research in hepatology and gastroenterology 2022. link 80 Greeviroj P, Lertussavavivat T, Thongsricome T, Takkavatakarn K, Phannajit J, Avihingsanon Y et al.. The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis. Journal of nephrology 2022. link 81 Im YR, Jagdish R, Leith D, Kim JU, Yoshida K, Majid A et al.. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis. The lancet. Gastroenterology & hepatology 2022. link00201-1) 82 Badur S, Öztürk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O et al.. Hepatitis A in the Eastern Mediterranean Region: a comprehensive review. Human vaccines & immunotherapeutics 2022. link 83 Iversen J, Wand H, Chan PL, Le LV, Maher L. Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region. Viruses 2022. link 84 Gurav YK, Bagepally BS, Thakkinstian A, Chaikledkaew U, Thavorncharoensap M. Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review. The Indian journal of medical research 2022. link 85 Afifi AM, Elgenidy A, Hashim M, Awad AK, Jalal PK. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Reviews in medical virology 2022. link 86 Chatziprodromidou IP, Dimitrakopoulou ME, Apostolou T, Katopodi T, Charalambous E, Vantarakis A. Hepatitis A and E in the Mediterranean: A systematic review. Travel medicine and infectious disease 2022. link 87 Weng MK, Doshani M, Khan MA, Frey S, Ault K, Moore KL et al.. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR. Morbidity and mortality weekly report 2022. link 88 Kanda T, Sasaki-Tanaka R, Nakamoto S. Hepatitis A Virus Infection and Molecular Research. International journal of molecular sciences 2022. link 89 Lhomme S. Special Issue "Recent Progress in Hepatitis A Virus Research". Viruses 2022. link 90 . Acute unexplained hepatitis in children. Bulletin of the World Health Organization 2022. link 91 . Update on the Global Pediatric Hepatitis Outbreak. The American journal of nursing 2022. link 92 El-Ghitany EM, Ashour A, Fekry MM, Elrewany E, Farghaly AG, Omran EA. Seroprevalence of Hepatitis A, B and C Among a Sample of Refugees in Egypt: An Exploratory Survey. Journal of epidemiology and global health 2022. link 93 Kantar FU, Kahraman S, Ece G, Cagırgan S. Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis. African health sciences 2022. link 94 Leven EA, Luo Y, Nguyen VT, Pourmand K. Enhanced Communication for Interhospital Transfers Increases Preparedness in an Academic Tertiary Care Center. Applied clinical informatics 2022. link 95 Tajiri H, Bessho K, Nakayama Y, Abukawa D, Iitsuka Y, Ito Y et al.. Clinical practice guidelines for the management of children with mother-to-child transmitted hepatitis C virus infection. Pediatrics international : official journal of the Japan Pediatric Society 2022. link 96 Verma N, Mishra S, Singh S, Kaur R, Kaur T, De A et al.. Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID-19 Pandemic. Hepatology communications 2022. link 97 Katchman H, Adelson M, Avitan O, Mattatov M, Sason A, Levitt S et al.. Hepatitis C Virus Elimination in Methadone-treated Patients: Implementation of Hepatology Clinic in a Methadone Treatment Program. Journal of addiction medicine 2022. link 98 Moura-Neto JA, Ferraz MLG, Bittencourt PL, Vieira Neto OM. Brazilian registry for the elimination of hepatitis C in dialysis units: a call to action for Nephrology. Jornal brasileiro de nefrologia 2022. link 99 Youssry S, Shalaby T, Maher AS, Ghoneim H. Association of hepatitis B vaccine response to vitamin D supplementation and ultraviolet B (UVB) exposure during different time intervals in experimental animals. Immunologic research 2022. link 100 Dabrowska-Leonik N, Sawicka-Powierza J, Bernatowska E, Pac M, Bernat-Sitarz K, Heropolitanska-Pliszka E et al.. Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age. PloS one 2022. link